0
0.5
1
1.5
2+
Viral clearance
79%
Improvement
Relative Risk
Time to viral-
41%
primary
Viral clearance (b)
32%
late
Paxlovid for COVID-19 Li et al. EARLY TREATMENT
Is early treatment with paxlovid beneficial for COVID-19?
Retrospective 399 patients in China (March - April 2022)
Improved viral clearance with paxlovid (p<0.000001)
c19early.org
Li et al., Clinical Infectious Diseases, Jul 2022
Favors paxlovid
Favors control